- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe late onset growth hormone deficiency (GHD)
- Meeting Date: September 2023
- Public Summary Document (PSD) September 2023 PBAC Meeting - (PDF 492KB)
- Public Summary Document (PSD) September 2023 PBAC Meeting - (Word 77KB)
Somatropin – September 2023
Somatropin: Solution for injection 6 mg (18 i.u.) in 1.03 mL cartridge (with preservative), Solution for injection 12 mg (36 i.u.) in 1.5 mL cartridge (with preservative); Saizen®- September 2023
Last updated
22 December 2023